nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”nodgo-806Research ArticleПОСТ-РЕЛИЗPOST RELEASEОбзор выступления в рамках II объединенного Конгресса НОДГО и РОДО: «Впервые в России. Клинические рекомендации по инфантильным гемангиомам»Overview of the speech at the II Joint Congress of NODGO and RODO: “For the first time in Russia. Clinical recommendations for infantile hemangiomas”РедакционнаяCтатьяEditorialArticle202230042022917273Copyright © Редакционная c., 20222022Редакционная c.Editorial a.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/806
.
.
ReferencesISSVA classification for vascular anomalies. Approved at the 20th ISSVA Workshop, Melbourne, April 2014, last revision, May, 2018. Available online: https://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf. Accessed on October 22, 2021.ISSVA classification for vascular anomalies. Approved at the 20th ISSVA Workshop, Melbourne, April 2014, last revision, May, 2018. Available online: https://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf. Accessed on October 22, 2021.Krowchuk D.P., Frieden I.J., Mancini A.J., Darrow D.H., Blei F., Greene A.K., Annam A., Baker C.N., Frommelt P.C., Hodak A., Pate B.M., Pelletier J.L., Sandrock D., Weinberg S.T., Whelan M.A., SUBCOMMITTEE ON THE MANAGEMENT OF INFANTILE HEMANGIOMAS. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019;143(1):e20183475. doi: 10.1542/peds.2018-3475.Krowchuk D.P., Frieden I.J., Mancini A.J., Darrow D.H., Blei F., Greene A.K., Annam A., Baker C.N., Frommelt P.C., Hodak A., Pate B.M., Pelletier J.L., Sandrock D., Weinberg S.T., Whelan M.A., SUBCOMMITTEE ON THE MANAGEMENT OF INFANTILE HEMANGIOMAS. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019;143(1):e20183475. doi: 10.1542/peds.2018-3475.Котлукова Н.П., Белышева Т.С., Валиев Т.Т., Константинова Н.К., Тележникова Н.Д., Лаврова Т.Р. Междисциплинарный подход к лечению младенческих гемангиом. Педиатрия. Журнал им. Г.Н. Сперанского. 2021;100(3):174–82.Kotlukova N.P., Belysheva T.S., Valiev T.T., Konstantinova N.K., Telezhnikova N.D., Lavrova T.R. Interdisciplinary approach to the treatment of infant hemangioma. Pediatriya. Zhurnal im. G.N. Speranskogo. = Pediatrics named after G.N. Speransky. 2021;100(3):174–82. (In Russ.)Satterfield K.R., Chamber C.B. Current treatment and management of infantile hemangiomas. Surv Opthalmol. 2019:64(5):608–18. doi: 10.1016/j.survophthal.2019.02.005.Satterfield K.R., Chamber C.B. Current treatment and management of infantile hemangiomas. Surv Opthalmol. 2019:64(5):608–18. doi: 10.1016/j.survophthal.2019.02.005.Инструкция по медицинскому применению препарата Гемангиол.Инструкция по медицинскому применению препарата Гемангиол.Sans V., Dumas de la Roque E., Berge J., Grenier N., Boralevi F., Mazereeuw-Hautier J., Lipsker D., Dupuis E., Ezzedine K., Vergnes P., Taïeb A., Léauté-Labrèze C. Propranolol for Severe Infantile Hemangiomas: Follow-Up Report. Pediatrics. 2009;124(3):e423–31. doi: 10.1542/peds.2008-3458.Sans V., Dumas de la Roque E., Berge J., Grenier N., Boralevi F., Mazereeuw-Hautier J., Lipsker D., Dupuis E., Ezzedine K., Vergnes P., Taïeb A., Léauté-Labrèze C. Propranolol for Severe Infantile Hemangiomas: Follow-Up Report. Pediatrics. 2009;124(3):e423–31. doi: 10.1542/peds.2008-3458.Thoumazet F., Leaute-Labreze C., Colin J., Mortemousque B. Efficacy of systemic propanolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients. Br J Ophthalmol. 2012;96(3):370–4. doi: 10.1136/bjophthalmol-2011-300047.Thoumazet F., Leaute-Labreze C., Colin J., Mortemousque B. Efficacy of systemic propanolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients. Br J Ophthalmol. 2012;96(3):370–4. doi: 10.1136/bjophthalmol-2011-300047.
The authors declare that there are no conflicts of interest present.